Given the reports of cognitive deficits in mice that express mutant APP and the association, in some cases, of these deficits with amyloid deposition, we sought to determine whether the BRI2-Aβ1-42 mice manifest detectable cognitive deficits. The gene discussed is ITM2B; the disease is Cognitive impairment.